Predicted to enable adipokinetic hormone receptor activity; adiponectin binding activity; and identical protein binding activity. Involved in several processes, including negative regulation of hepatic stellate cell migration; positive regulation of glucose import; and response to fructose. Predicted to be intrinsic component of plasma membrane. Predicted to be active in plasma membrane. Biomarker of end stage renal disease; fatty liver disease (multiple); glucose metabolism disease (multiple); and obesity. Human ortholog(s) of this gene implicated in non-alcoholic fatty liver disease and type 2 diabetes mellitus. Orthologous to human ADIPOR2 (adiponectin receptor 2). [provided by Alliance of Genome Resources, Apr 2022]